Schrödinger, Inc. (SDGR)
NASDAQ: SDGR · Real-Time Price · USD
22.06
-0.43 (-1.89%)
Dec 3, 2024, 1:34 PM EST - Market open
Schrödinger Employees
Schrödinger had 867 employees as of December 31, 2023. The number of employees increased by 80 or 10.17% compared to the previous year.
Employees
867
Change (1Y)
80
Growth (1Y)
10.17%
Revenue / Employee
$223,008
Profits / Employee
-$204,818
Market Cap
1.61B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 867 | 80 | 10.17% |
Dec 31, 2022 | 787 | 123 | 18.52% |
Dec 31, 2021 | 664 | 212 | 46.90% |
Dec 31, 2020 | 452 | 58 | 14.72% |
Dec 31, 2019 | 394 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Evotec SE | 5,061 |
InMode | 581 |
Intellia Therapeutics | 526 |
Immunocore Holdings | 497 |
Dynavax Technologies | 408 |
Travere Therapeutics | 380 |
Kiniksa Pharmaceuticals International, | 297 |
Neumora Therapeutics | 124 |
SDGR News
- 14 days ago - Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 15 days ago - Schrödinger Broadens and Accelerates Predictive Toxicology Initiative - Business Wire
- 21 days ago - Schrödinger (SDGR) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 21 days ago - Schrödinger Reports Third Quarter 2024 Financial Results - Business Wire
- 4 weeks ago - Schrödinger to Present at Jefferies London Healthcare Conference - Business Wire
- 4 weeks ago - Schrödinger to Announce Third Quarter 2024 Financial Results on November 12 - Business Wire
- 5 weeks ago - Schrödinger Presents SGR-3515 Preclinical Data at 2024 EORTC-NCI-AACR Symposium - Business Wire
- 7 weeks ago - Schrödinger to Present New Preclinical SGR-3515 and PRMT5-MTA Data at 2024 EORTC-NCI-AACR Symposium - Business Wire